Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
CNCE - As of  04/30/25, 10:08:43 AM:   35 Insider Transactions.

Sector: Healthcare    Industry: Biotechnology
Prev Close:$11.96  Avg Vol(3m): 151,062  P/E: 14.30  EPS: 0.83

Email this page to a friend.    Insider Transactions for CNCE

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
S 2020-02-14 15:13:48.0 CONCERT PHARMACEUTICALS CNCE BIOTECHNOLOGY VALUE FUND L P 0.0% view
B 2020-02-14 13:30:43.0 CONCERT PHARMACEUTICALS CNCE RTW INVESTMENTS 1.0% view
B 2020-02-14 12:57:51.0 CONCERT PHARMACEUTICALS CNCE BANK OF AMERICA CORP 7.6% view
B 2020-02-12 10:43:32.0 CONCERT PHARMACEUTICALS CNCE DIMENSIONAL FUND ADVISORS LP 5.07% view
B 2020-02-06 13:34:51.0 CONCERT PHARMACEUTICALS CNCE Arkin Moshe 2.05% view
S 2020-02-05 11:26:05.0 CONCERT PHARMACEUTICALS CNCE BlackRock Inc 6.3% view
B 2020-01-23 14:21:51.0 CONCERT PHARMACEUTICALS CNCE INGALLS & SNYDER LLC 6.1% view
S 2019-07-03 15:31:31.0 CONCERT PHARMACEUTICALS CNCE BIOTECHNOLOGY VALUE FUND L P 5.9% view
B 2019-04-02 14:50:20.0 CONCERT PHARMACEUTICALS CNCE BIOTECHNOLOGY VALUE FUND L P 11.8% view
S 2019-02-07 17:17:02.0 CONCERT PHARMACEUTICALS CNCE BIOTECHNOLOGY VALUE FUND L P 5.9% view
S 2019-02-07 17:11:08.0 CONCERT PHARMACEUTICALS CNCE BIOTECHNOLOGY VALUE FUND L P 4.9% view
S 2019-02-04 10:07:42.0 CONCERT PHARMACEUTICALS CNCE BlackRock Inc 7.3% view
S 2019-01-30 08:46:20.0 CONCERT PHARMACEUTICALS CNCE INGALLS & SNYDER LLC 5.1% view
B 2018-11-23 16:00:34.0 CONCERT PHARMACEUTICALS CNCE PERCEPTIVE ADVISORS LLC 5.2% view
S 2018-02-14 14:33:14.0 CONCERT PHARMACEUTICALS CNCE BIOTECHNOLOGY VALUE FUND L P 8.7% view
S 2018-02-13 16:35:26.0 CONCERT PHARMACEUTICALS CNCE GLAXOSMITHKLINE PLC 5.2% view
B 2018-02-09 17:12:21.0 CONCERT PHARMACEUTICALS CNCE INGALLS & SNYDER LLC 5.87% view
B 2018-02-05 16:20:37.0 CONCERT PHARMACEUTICALS CNCE TVM Life Science Ventures VI GmbH & Co KG n/a view
B 2018-02-01 09:26:38.0 CONCERT PHARMACEUTICALS CNCE BlackRock Inc 7.8% view
B 2017-03-16 16:01:25.0 CONCERT PHARMACEUTICALS CNCE GREAT POINT PARTNERS LLC 9.41% view
S 2017-03-09 10:45:38.0 CONCERT PHARMACEUTICALS CNCE BlackRock Inc 4.97% view
B 2017-02-14 12:30:20.0 CONCERT PHARMACEUTICALS CNCE BIOTECHNOLOGY VALUE FUND L P 11.8% view
B 2017-02-13 16:44:32.0 CONCERT PHARMACEUTICALS CNCE SENZAR ASSET MANAGEMENT 10.6% view
S 2017-01-23 14:17:58.0 CONCERT PHARMACEUTICALS CNCE BlackRock Inc 5.1% view
S 2016-03-04 15:59:33.0 CONCERT PHARMACEUTICALS CNCE THREE ARCH PARTNERS IV LP 0.0% view
S 2016-02-16 15:47:18.0 CONCERT PHARMACEUTICALS CNCE BIOTECHNOLOGY VALUE FUND L P 10.1% view
B 2016-01-28 15:45:48.0 CONCERT PHARMACEUTICALS CNCE BlackRock Inc 5.8% view
B 2015-05-28 17:16:06.0 CONCERT PHARMACEUTICALS CNCE BIOTECHNOLOGY VALUE FUND L P 11.0% view
B 2015-03-09 10:01:22.0 CONCERT PHARMACEUTICALS CNCE SENZAR ASSET MANAGEMENT 10.6% view
B 2015-02-17 14:35:42.0 CONCERT PHARMACEUTICALS CNCE THREE ARCH PARTNERS IV LP 6.3% view
B 2015-02-17 13:11:06.0 CONCERT PHARMACEUTICALS CNCE BROOKSIDE CAPITAL PARTNERS FUND LP 0.0% view
B 2015-02-17 06:07:25.0 CONCERT PHARMACEUTICALS CNCE Skyline Venture Partners Qualified Purchaser Fund IV L P 6.6% view
B 2015-02-12 18:39:07.0 CONCERT PHARMACEUTICALS CNCE GLAXOSMITHKLINE PLC 7.5% view
B 2014-09-12 16:10:26.0 CONCERT PHARMACEUTICALS CNCE BIOTECHNOLOGY VALUE FUND L P 6.7% view
B 2014-03-03 09:26:06.0 CONCERT PHARMACEUTICALS CNCE BROOKSIDE CAPITAL MANAGEMENT LLC 6.67% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.